(CTLA-4) gene is a member of the immunoglobulin super family. It encodes a protein which transmits an inhibitory signal to T-cells. Because of its inhibitory role, CTLA-4 is a strong candidate susceptibility gene in autoimmunity.
The human CTLA-4 gene consists of four exons and three introns. [1] There are at least three well-studied polymorphic markers: a C/T substitution at position-318
of the promoter region, [2] an A/G transition at position 49 of exon 1 (A49G) which causes a threonine-to-alanine substitution in codon 17 of the leader peptide (A17T); [3] and, an (AT)n dinucleotide repeat polymorphism located in the 3' untranslated region of exon 4. [4] The A/G polymorphism at position +49 in exon 1 of the CTLA-4 gene has been extensively studied in autoimmune disorders and is found associated with Graves' disease,
Hashimoto's thyroiditis and multiple sclerosis including A/G (codon 17 Thr/Ala) polymorphism, with T1DM was studied in Madurai population.
Type 1 diabetes
Type 1 diabetes mellitus is a T-cell mediated organ specific autoimmune disease characterized by the destruction of insulin secreting β cells of the islets of Langehans in the pancreas. [3] The worldwide prevalence of diabetes is continuing to increase. In the year 2000, there were 151 million people with diabetes. This number
Introduction
Cytotoxic T lymphocyte-associated antigen 4 is expected to reach 300 million in the year 2025.
Presently, India leads the world with the largest number of adults with diabetes. [5] Diabetes mellitus includes a group of metabolic disorders that is characterized by hyperglycemia and leads to long term macro and micro vascular complications. [6] The most striking increase has been found in Finland but in Asian countries, the incidence is comparatively low. The incidence of Type 1 diabetes in south India has been reported to be 10.5 cases/100,000 per year. [7] There are over 20 regions in the human genome that are associated with TIDM, but most of it make only small contribution to the susceptibility of type 1 diabetes. [8] T1DM has been reported to be strongly associated with HLA-DR3 and or DR4. [9] Insulin gene localized on chromosome 11p15, [11]
Cytotoxic T lymphocyte-associated antigen 4 gene and autoimmunity
The CTLA-4 gene is located on the long arm of the chromosome 2q33. [12] It consists of 4 exons and 3 introns.
Exon 1 encodes a leather peptide sequence, exon 2 codes for an immunoglobulin domain, exon 3 and 4 codes for the hydrophobic transmembrane domain, and the cytoplasmic domain respectively. [13] Several studies have
shown the association of CTLA-4 gene with autoimmune diseases. [14] The CTLA-4 gene encodes T-cell receptor involved in the control of proliferation and mediates T-cell apoptosis. [15] The receptor protein is a specifi c T lymphocyte surface antigen that is detected on cells only after antigen presentation. Thus, CTLA-4 is directly involved in both immune and autoimmune responses. [16] Experiments showed that CTLA-4 defi cient mice develop a severe lymphoproliferative disease with multiorgan [18]
Materials and Methods
Fifty three clinically proven Type 1 diabetes patients and control subjects with no history of autoimmune disease within the age group of 10-50 were selected for the study. Peripheral blood from both patient and the control group was collected in EDTA coated tubes and genomic Deoxyribonucleic Acid (DNA) was extracted from the same following the protocol from Sambrook and
Russel. [19] Isolated DNA was confi rmed electrophoretically Reverse primer (5'-AGTCTCACTCACCTTTGCAG-3') [20] (Fermentas Life Sciences, Germany), ~200 ng Genomic 
Results
The study was conducted on a group comprising of 53 TIDM patients and 53 controls. Among the T1DM
Patients 38 (71.7%) were male and 15 (28.3%) were female. The male and female ratio was maintained same in the control group too. The age group of the patients and the control population was in the range of 10-50
years. The study clearly showed that the male population was found to be more susceptible to T1DM and 30.2%
of the patients showed family history of type I diabetes.
In the present study, genomic DNA was isolated from the blood of both the patients and the controls and the isolated DNA was confi rmed using 0.7% agarose gel.
The high molecular weight and slow migrating DNA was found migrating just under the wells and indicated that our methods yielded undegraded DNA as seen in Figure 1 . In the present study, A/G genotype was observed in 
Discussion
The present study was carried out at Madurai, a city High frequency of G allele in type 1 diabetic patients in Chinese, Korean, Spanish, [21] Italian, [22] and Belgian population. [3] Makes it evident that CTLA-4 gene is a T-cells and even can alter the peptide sequence. [14] CTLA-4 monoclonal antibody based treatment may be useful to overcome the effect of mutation. However, 
